Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Finnish AQ BioTech raises €2.5M in seed funding to expand cancer screening technology into China.

PRIVATESep 10, 2026•about 4 hours ago

Amount Raised

€2.5 Million

Round Type

Seed

FinlandBiotechnologyHealth Care

Description

AQ BioTech, a Finnish biotechnology company, has closed a €2.5 million seed funding round to support its international expansion and technology development. The capital will enable the company to scale its next-generation biomarker discovery platform and establish partnerships in China. AQ BioTech develops technology for biomarker discovery to support drug development and personalized healthcare approaches. The funding reflects growing Nordic interest in targeting China's biotechnology sector.

Company Information

Company

AQ BioTech

Location

Finland

About

AQ BioTech is a Finnish biotechnology company that develops technology for biomarker discovery to identify biological indicators linked to diseases and health conditions. The company's technology supports drug development and enables more personalized approaches to healthcare. AQ BioTech is expanding internationally with a focus on the Chinese market to develop partnerships and grow its presence in the biotechnology sector.

Don't miss AQ BioTech's next move

Get an email the moment AQ BioTech raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for AQ BioTech's next move

See what Strategic adds

AQ BioTech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.